Global Respiratory Disorders Drug Market Research Report 2022

Global Respiratory Disorders Drug Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disorders Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Suspension Agent
1.2.4 Injection
1.2.5 Gas (Powder) Mist
1.2.6 Tablets
1.2.7 Solution
1.2.8 Granules
1.2.9 Dropping Pill
1.2.10 Patch
1.2.11 Other
1.3 Market by Application
1.3.1 Global Respiratory Disorders Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clearing Away Heat And Detoxifying Drugs
1.3.3 Expectorant
1.3.4 Cold Medicine
1.3.5 Antiasthmatic
1.3.6 COPD Treatment Medicine
1.3.7 Cough Medicine
1.3.8 Respiratory Stimulant
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disorders Drug Market Perspective (2017-2028)
2.2 Respiratory Disorders Drug Growth Trends by Region
2.2.1 Respiratory Disorders Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Disorders Drug Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Disorders Drug Market Dynamics
2.3.1 Respiratory Disorders Drug Industry Trends
2.3.2 Respiratory Disorders Drug Market Drivers
2.3.3 Respiratory Disorders Drug Market Challenges
2.3.4 Respiratory Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disorders Drug Players by Revenue
3.1.1 Global Top Respiratory Disorders Drug Players by Revenue (2017-2022)
3.1.2 Global Respiratory Disorders Drug Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Disorders Drug Revenue
3.4 Global Respiratory Disorders Drug Market Concentration Ratio
3.4.1 Global Respiratory Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drug Revenue in 2021
3.5 Respiratory Disorders Drug Key Players Head office and Area Served
3.6 Key Players Respiratory Disorders Drug Product Solution and Service
3.7 Date of Enter into Respiratory Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disorders Drug Breakdown Data by Type
4.1 Global Respiratory Disorders Drug Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028)
5 Respiratory Disorders Drug Breakdown Data by Application
5.1 Global Respiratory Disorders Drug Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Disorders Drug Market Size (2017-2028)
6.2 North America Respiratory Disorders Drug Market Size by Country (2017-2022)
6.3 North America Respiratory Disorders Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Respiratory Disorders Drug Market Size (2017-2028)
7.2 Europe Respiratory Disorders Drug Market Size by Country (2017-2022)
7.3 Europe Respiratory Disorders Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disorders Drug Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Disorders Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Respiratory Disorders Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Respiratory Disorders Drug Market Size (2017-2028)
9.2 Latin America Respiratory Disorders Drug Market Size by Country (2017-2022)
9.3 Latin America Respiratory Disorders Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disorders Drug Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Respiratory Disorders Drug Introduction
11.1.4 AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022)
11.1.5 AstraZeneca Recent Development
11.2 MSD
11.2.1 MSD Company Detail
11.2.2 MSD Business Overview
11.2.3 MSD Respiratory Disorders Drug Introduction
11.2.4 MSD Revenue in Respiratory Disorders Drug Business (2017-2022)
11.2.5 MSD Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Respiratory Disorders Drug Introduction
11.3.4 Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Biogen
11.4.1 Biogen Company Detail
11.4.2 Biogen Business Overview
11.4.3 Biogen Respiratory Disorders Drug Introduction
11.4.4 Biogen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.4.5 Biogen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Respiratory Disorders Drug Introduction
11.5.4 Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Respiratory Disorders Drug Introduction
11.6.4 Teva Revenue in Respiratory Disorders Drug Business (2017-2022)
11.6.5 Teva Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Respiratory Disorders Drug Introduction
11.7.4 Novartis Revenue in Respiratory Disorders Drug Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Respiratory Disorders Drug Introduction
11.8.4 Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022)
11.8.5 Johnson & Johnson Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Respiratory Disorders Drug Introduction
11.9.4 Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022)
11.9.5 Eli Lilly Recent Development
11.10 Otsuka
11.10.1 Otsuka Company Detail
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Respiratory Disorders Drug Introduction
11.10.4 Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022)
11.10.5 Otsuka Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Respiratory Disorders Drug Introduction
11.11.4 Merck Revenue in Respiratory Disorders Drug Business (2017-2022)
11.11.5 Merck Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda Respiratory Disorders Drug Introduction
11.12.4 Takeda Revenue in Respiratory Disorders Drug Business (2017-2022)
11.12.5 Takeda Recent Development
11.13 FibroGen
11.13.1 FibroGen Company Detail
11.13.2 FibroGen Business Overview
11.13.3 FibroGen Respiratory Disorders Drug Introduction
11.13.4 FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.13.5 FibroGen Recent Development
11.14 Amgen
11.14.1 Amgen Company Detail
11.14.2 Amgen Business Overview
11.14.3 Amgen Respiratory Disorders Drug Introduction
11.14.4 Amgen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.14.5 Amgen Recent Development
11.15 Dr. Reddy's Laboratories
11.15.1 Dr. Reddy's Laboratories Company Detail
11.15.2 Dr. Reddy's Laboratories Business Overview
11.15.3 Dr. Reddy's Laboratories Respiratory Disorders Drug Introduction
11.15.4 Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022)
11.15.5 Dr. Reddy's Laboratories Recent Development
11.16 Dainippon Sumitomo
11.16.1 Dainippon Sumitomo Company Detail
11.16.2 Dainippon Sumitomo Business Overview
11.16.3 Dainippon Sumitomo Respiratory Disorders Drug Introduction
11.16.4 Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.16.5 Dainippon Sumitomo Recent Development
11.17 Abbott
11.17.1 Abbott Company Detail
11.17.2 Abbott Business Overview
11.17.3 Abbott Respiratory Disorders Drug Introduction
11.17.4 Abbott Revenue in Respiratory Disorders Drug Business (2017-2022)
11.17.5 Abbott Recent Development
11.18 Horizon Pharma
11.18.1 Horizon Pharma Company Detail
11.18.2 Horizon Pharma Business Overview
11.18.3 Horizon Pharma Respiratory Disorders Drug Introduction
11.18.4 Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.18.5 Horizon Pharma Recent Development
11.19 Zambon
11.19.1 Zambon Company Detail
11.19.2 Zambon Business Overview
11.19.3 Zambon Respiratory Disorders Drug Introduction
11.19.4 Zambon Revenue in Respiratory Disorders Drug Business (2017-2022)
11.19.5 Zambon Recent Development
11.20 Moehs
11.20.1 Moehs Company Detail
11.20.2 Moehs Business Overview
11.20.3 Moehs Respiratory Disorders Drug Introduction
11.20.4 Moehs Revenue in Respiratory Disorders Drug Business (2017-2022)
11.20.5 Moehs Recent Development
11.21 Pharmazell
11.21.1 Pharmazell Company Detail
11.21.2 Pharmazell Business Overview
11.21.3 Pharmazell Respiratory Disorders Drug Introduction
11.21.4 Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022)
11.21.5 Pharmazell Recent Development
11.22 Nippon Rika
11.22.1 Nippon Rika Company Detail
11.22.2 Nippon Rika Business Overview
11.22.3 Nippon Rika Respiratory Disorders Drug Introduction
11.22.4 Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022)
11.22.5 Nippon Rika Recent Development
11.23 Chengyi Pharma
11.23.1 Chengyi Pharma Company Detail
11.23.2 Chengyi Pharma Business Overview
11.23.3 Chengyi Pharma Respiratory Disorders Drug Introduction
11.23.4 Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.23.5 Chengyi Pharma Recent Development
11.24 Wuhan Grand Hoyo
11.24.1 Wuhan Grand Hoyo Company Detail
11.24.2 Wuhan Grand Hoyo Business Overview
11.24.3 Wuhan Grand Hoyo Respiratory Disorders Drug Introduction
11.24.4 Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.24.5 Wuhan Grand Hoyo Recent Development
11.25 Manus Aktteva Biopharma
11.25.1 Manus Aktteva Biopharma Company Detail
11.25.2 Manus Aktteva Biopharma Business Overview
11.25.3 Manus Aktteva Biopharma Respiratory Disorders Drug Introduction
11.25.4 Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.25.5 Manus Aktteva Biopharma Recent Development
11.26 Beijing Jiuhe Pharmaceutical
11.26.1 Beijing Jiuhe Pharmaceutical Company Detail
11.26.2 Beijing Jiuhe Pharmaceutical Business Overview
11.26.3 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Introduction
11.26.4 Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.26.5 Beijing Jiuhe Pharmaceutical Recent Development
11.27 Daiichi Sankyo Pharmaceutical
11.27.1 Daiichi Sankyo Pharmaceutical Company Detail
11.27.2 Daiichi Sankyo Pharmaceutical Business Overview
11.27.3 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Introduction
11.27.4 Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.27.5 Daiichi Sankyo Pharmaceutical Recent Development
11.28 Sinopharm
11.28.1 Sinopharm Company Detail
11.28.2 Sinopharm Business Overview
11.28.3 Sinopharm Respiratory Disorders Drug Introduction
11.28.4 Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022)
11.28.5 Sinopharm Recent Development
11.29 CTTQ
11.29.1 CTTQ Company Detail
11.29.2 CTTQ Business Overview
11.29.3 CTTQ Respiratory Disorders Drug Introduction
11.29.4 CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022)
11.29.5 CTTQ Recent Development
11.30 Yangtze River Pharmaceutical Group
11.30.1 Yangtze River Pharmaceutical Group Company Detail
11.30.2 Yangtze River Pharmaceutical Group Business Overview
11.30.3 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Introduction
11.30.4 Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022)
11.30.5 Yangtze River Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Respiratory Disorders Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Capsule
Table 3. Key Players of Suspension Agent
Table 4. Key Players of Injection
Table 5. Key Players of Gas (Powder) Mist
Table 6. Key Players of Tablets
Table 7. Key Players of Solution
Table 8. Key Players of Granules
Table 9. Key Players of Dropping Pill
Table 10. Key Players of Patch
Table 11. Key Players of Other
Table 12. Global Respiratory Disorders Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Respiratory Disorders Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Respiratory Disorders Drug Market Share by Region (2017-2022)
Table 16. Global Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Respiratory Disorders Drug Market Share by Region (2023-2028)
Table 18. Respiratory Disorders Drug Market Trends
Table 19. Respiratory Disorders Drug Market Drivers
Table 20. Respiratory Disorders Drug Market Challenges
Table 21. Respiratory Disorders Drug Market Restraints
Table 22. Global Respiratory Disorders Drug Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Respiratory Disorders Drug Market Share by Players (2017-2022)
Table 24. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Table 25. Ranking of Global Top Respiratory Disorders Drug Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Respiratory Disorders Drug Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Respiratory Disorders Drug Product Solution and Service
Table 29. Date of Enter into Respiratory Disorders Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Respiratory Disorders Drug Revenue Market Share by Type (2017-2022)
Table 33. Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Respiratory Disorders Drug Revenue Market Share by Type (2023-2028)
Table 35. Global Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Respiratory Disorders Drug Revenue Market Share by Application (2017-2022)
Table 37. Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Respiratory Disorders Drug Revenue Market Share by Application (2023-2028)
Table 39. North America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia-Pacific Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 44. Asia-Pacific Respiratory Disorders Drug Market Size by Region (2023-2028) & (US$ Million)
Table 45. Latin America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 46. Latin America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 47. Middle East & Africa Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 48. Middle East & Africa Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Respiratory Disorders Drug Product
Table 52. AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. MSD Company Detail
Table 55. MSD Business Overview
Table 56. MSD Respiratory Disorders Drug Product
Table 57. MSD Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 58. MSD Recent Development
Table 59. Boehringer Ingelheim Company Detail
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Respiratory Disorders Drug Product
Table 62. Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. Biogen Company Detail
Table 65. Biogen Business Overview
Table 66. Biogen Respiratory Disorders Drug Product
Table 67. Biogen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 68. Biogen Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Respiratory Disorders Drug Product
Table 72. Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Teva Company Detail
Table 75. Teva Business Overview
Table 76. Teva Respiratory Disorders Drug Product
Table 77. Teva Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 78. Teva Recent Development
Table 79. Novartis Company Detail
Table 80. Novartis Business Overview
Table 81. Novartis Respiratory Disorders Drug Product
Table 82. Novartis Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Respiratory Disorders Drug Product
Table 87. Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Respiratory Disorders Drug Product
Table 92. Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Otsuka Company Detail
Table 95. Otsuka Business Overview
Table 96. Otsuka Respiratory Disorders Drug Product
Table 97. Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 98. Otsuka Recent Development
Table 99. Merck Company Detail
Table 100. Merck Business Overview
Table 101. Merck Respiratory Disorders DrugProduct
Table 102. Merck Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 103. Merck Recent Development
Table 104. Takeda Company Detail
Table 105. Takeda Business Overview
Table 106. Takeda Respiratory Disorders DrugProduct
Table 107. Takeda Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. FibroGen Company Detail
Table 110. FibroGen Business Overview
Table 111. FibroGen Respiratory Disorders DrugProduct
Table 112. FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 113. FibroGen Recent Development
Table 114. Amgen Company Detail
Table 115. Amgen Business Overview
Table 116. Amgen Respiratory Disorders DrugProduct
Table 117. Amgen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 118. Amgen Recent Development
Table 119. Dr. Reddy's Laboratories Company Detail
Table 120. Dr. Reddy's Laboratories Business Overview
Table 121. Dr. Reddy's Laboratories Respiratory Disorders DrugProduct
Table 122. Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 123. Dr. Reddy's Laboratories Recent Development
Table 124. Dainippon Sumitomo Company Detail
Table 125. Dainippon Sumitomo Business Overview
Table 126. Dainippon Sumitomo Respiratory Disorders DrugProduct
Table 127. Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 128. Dainippon Sumitomo Recent Development
Table 129. Abbott Company Detail
Table 130. Abbott Business Overview
Table 131. Abbott Respiratory Disorders DrugProduct
Table 132. Abbott Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 133. Abbott Recent Development
Table 134. Horizon Pharma Company Detail
Table 135. Horizon Pharma Business Overview
Table 136. Horizon Pharma Respiratory Disorders DrugProduct
Table 137. Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 138. Horizon Pharma Recent Development
Table 139. Zambon Company Detail
Table 140. Zambon Business Overview
Table 141. Zambon Respiratory Disorders DrugProduct
Table 142. Zambon Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 143. Zambon Recent Development
Table 144. Moehs Company Detail
Table 145. Moehs Business Overview
Table 146. Moehs Respiratory Disorders DrugProduct
Table 147. Moehs Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 148. Moehs Recent Development
Table 149. Pharmazell Company Detail
Table 150. Pharmazell Business Overview
Table 151. Pharmazell Respiratory Disorders DrugProduct
Table 152. Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 153. Pharmazell Recent Development
Table 154. Nippon Rika Company Detail
Table 155. Nippon Rika Business Overview
Table 156. Nippon Rika Respiratory Disorders DrugProduct
Table 157. Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 158. Nippon Rika Recent Development
Table 159. Chengyi Pharma Company Detail
Table 160. Chengyi Pharma Business Overview
Table 161. Chengyi Pharma Respiratory Disorders DrugProduct
Table 162. Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 163. Chengyi Pharma Recent Development
Table 164. Wuhan Grand Hoyo Company Detail
Table 165. Wuhan Grand Hoyo Business Overview
Table 166. Wuhan Grand Hoyo Respiratory Disorders DrugProduct
Table 167. Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 168. Wuhan Grand Hoyo Recent Development
Table 169. Manus Aktteva Biopharma Company Detail
Table 170. Manus Aktteva Biopharma Business Overview
Table 171. Manus Aktteva Biopharma Respiratory Disorders DrugProduct
Table 172. Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 173. Manus Aktteva Biopharma Recent Development
Table 174. Beijing Jiuhe Pharmaceutical Company Detail
Table 175. Beijing Jiuhe Pharmaceutical Business Overview
Table 176. Beijing Jiuhe Pharmaceutical Respiratory Disorders DrugProduct
Table 177. Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 178. Beijing Jiuhe Pharmaceutical Recent Development
Table 179. Daiichi Sankyo Pharmaceutical Company Detail
Table 180. Daiichi Sankyo Pharmaceutical Business Overview
Table 181. Daiichi Sankyo Pharmaceutical Respiratory Disorders DrugProduct
Table 182. Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 183. Daiichi Sankyo Pharmaceutical Recent Development
Table 184. Sinopharm Company Detail
Table 185. Sinopharm Business Overview
Table 186. Sinopharm Respiratory Disorders DrugProduct
Table 187. Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 188. Sinopharm Recent Development
Table 189. CTTQ Company Detail
Table 190. CTTQ Business Overview
Table 191. CTTQ Respiratory Disorders DrugProduct
Table 192. CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 193. CTTQ Recent Development
Table 194. Yangtze River Pharmaceutical Group Company Detail
Table 195. Yangtze River Pharmaceutical Group Business Overview
Table 196. Yangtze River Pharmaceutical Group Respiratory Disorders DrugProduct
Table 197. Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 198. Yangtze River Pharmaceutical Group Recent Development
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Disorders Drug Market Share by Type: 2021 VS 2028
Figure 2. Capsule Features
Figure 3. Suspension Agent Features
Figure 4. Injection Features
Figure 5. Gas (Powder) Mist Features
Figure 6. Tablets Features
Figure 7. Solution Features
Figure 8. Granules Features
Figure 9. Dropping Pill Features
Figure 10. Patch Features
Figure 11. Other Features
Figure 12. Global Respiratory Disorders Drug Market Share by Application in 2021 & 2028
Figure 13. Clearing Away Heat And Detoxifying Drugs Case Studies
Figure 14. Expectorant Case Studies
Figure 15. Cold Medicine Case Studies
Figure 16. Antiasthmatic Case Studies
Figure 17. COPD Treatment Medicine Case Studies
Figure 18. Cough Medicine Case Studies
Figure 19. Respiratory Stimulant Case Studies
Figure 20. Other Case Studies
Figure 21. Respiratory Disorders Drug Report Years Considered
Figure 22. Global Respiratory Disorders Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 23. Global Respiratory Disorders Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 24. Global Respiratory Disorders Drug Market Share by Region: 2021 VS 2028
Figure 25. Global Respiratory Disorders Drug Market Share by Players in 2021
Figure 26. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Figure 27. The Top 10 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2021
Figure 28. North America Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. North America Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 30. United States Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Canada Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Europe Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Europe Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 34. Germany Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. France Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. U.K. Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Italy Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Russia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Nordic Countries Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Asia-Pacific Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Asia-Pacific Respiratory Disorders Drug Market Share by Region (2017-2028)
Figure 42. China Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Latin America Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Latin America Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 50. Mexico Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 54. Turkey Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 57. MSD Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 58. Boehringer Ingelheim Rev

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177

The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......

Global Digital Watermark Technology Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......

Global Location Based Marketing Services Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......

Global Auto Repair and Beauty Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72

The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......

Global Viral Vector Development Service Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......

Global Building Automation Systems (BAS) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......

Global SLAM in Mobile Robots and Smart AR Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92

This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......

Global Digital Educational Publishing Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......

Global Human Source Service Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs